[1]
Chopra, S., Shetty, N., Goel, M., Engineer, R., Rajamanickam, K., Kulkarni, S., Polnaya, A., Patkar, S., Ostwal, V., Ramadwar, M., Swamidas, J., Phurailatpam, R., Paul, S.N., Dhandpani, E., Joshi, K., Kannan, S., Rangarajan, V., Mehta, S., Patil, P. and Shrivastava, S.K. 2017. Protocol for an integrated phase II/III randomised controlled trial of transarterial chemotherapy and sorafenib with or without stereotactic body radiation therapy in patients with nonmetastatic unresectable hepatocellular carcinoma. International Journal of Clinical Trials. 4, 1 (Jan. 2017), 31–38. DOI:https://doi.org/10.18203/2349-3259.ijct20170306.